FMDGX | PMBJX | FMDGX / PMBJX | |
Total Expense Ratio | 0.05 | 0.78 | 6% |
Annual Report Gross Expense Ratio | 0.05 | 0.78 | 6% |
Fund Existence | 6 years | 24 years | - |
Gain YTD | 5.474 | 1.960 | 279% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.53B | 30.6B | 8% |
Annual Yield % from dividends | 0.44 | 0.06 | 764% |
Returns for 1 year | 21.91 | 10.12 | 217% |
Returns for 3 years | 75.90 | 48.96 | 155% |
Returns for 5 years | 70.02 | 53.13 | 132% |
Returns for 10 years | N/A | 88.94 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SHPAX | 19.06 | -0.09 | -0.47% |
Saratoga Health & Biotechnology A | |||
PGOFX | 49.79 | -0.56 | -1.11% |
Victory Pioneer Select Mid Cap Growth A | |||
DEMIX | 24.56 | -0.29 | -1.17% |
Macquarie Emerging Markets Instl | |||
VREMX | 8.23 | -0.10 | -1.20% |
Virtus SGA Emerging Markets Equity R6 | |||
ALGCX | 16.74 | -0.24 | -1.41% |
Alger International Opportunities C |